In severe COVID-19 patients, an apparent hypofibrinolysis has been observed, which could be related to the ceaseless engagement of AnxA2 with viral replication, rendering it unavailable for its typical function of tPA mediated conversion of plasminogen to plasmin, a major participant in fibrinolysis [104,114]. Here, ANXA2 is linked to COVID-19.